4189 JPX Week ended 07 Aug 2026

Weekly Investor Report

KH Neochem Co., Ltd. · Basic Materials · Chemicals

Open interactive chart View report data
Latest close 3,510 JPY
6.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 23.6% above the Trend Line and sits at 96.9% of its 52-week range. The latest completed week returned 6.2%, after a 19.3% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.

Setup score 76 out of 100
Latest Close 3,510 JPY 7 Aug 2026
1W Return 6.2% latest completed week
4W Return 19.3% short-term follow-through
12W Return 32.8% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 2.7x vs 13-week average
What is working
  • The trend backdrop is active with a 7-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 4 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.2% Latest completed week; four-week move 19.3%. Indicator stack 60/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 4 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 23.6% above the Trend Line and sits at 96.9% of its 52-week range. The latest completed week returned 6.2%, after a 19.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7212-week average 0.51

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.72Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 19.3% over four weeks, 32.8% over 12 weeks, and 28.9% over one year. The current trend has remained active for 7 consecutive weeks.

Performance by holding period

1W6.2%
4W19.3%
12W32.8%
26W27.9%
52W28.9%
Active trend streak7 weeks
Active weeks in one year34
Trend breadth65.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.24Latest activity-pressure read.
Pressure change762.3%Four-week change in activity pressure.
Leadership6.55Latest relative-leadership reading.
RS change139.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

0 positive · 4 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.1%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+8.9%Week of 13 Feb.
Worst week-6.3%Week of 13 Mar.
Latest week+6.2%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains8
Flat weeks0
Modest losses8
Sharp losses3
Recent vol3.4%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape71/100

Trend, activity pressure, participation, and risk combine to a 71/100 tape read.

 Indicator analysis46/100

Latest 12-week confirmation: trend 10/12, activity pressure 5/12, relative leadership 2/12.

Activity pressure 0.72; 4 reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

KH Neochem (TSE:4189) Stock Faces Revenue Pressure Despite Stronger Margins Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20263,510 JPY6.2%2,840 JPY2,334 JPY1.246.551.8MOn
31 Jul 20263,305 JPY7.7%2,805 JPY2,325 JPY0.991.821.3MOn
24 Jul 20263,070 JPY2.6%2,777 JPY2,316 JPY0.68-6.38419.0KOn
17 Jul 20262,991 JPY1.7%2,757 JPY2,310 JPY0.50-8.75743.0KOn
10 Jul 20262,941 JPY-1.4%2,739 JPY2,304 JPY0.14-16.64552.1KOn
3 Jul 20262,982 JPY1.6%2,722 JPY2,298 JPY-0.30-17.67116.4KOn
26 Jun 20262,934 JPY6.7%2,702 JPY2,292 JPY-0.67-19.19234.6KOn
19 Jun 20262,748 JPY5.0%2,685 JPY2,287 JPY-0.86-26.83132.2KOff
12 Jun 20262,618 JPY0.2%2,670 JPY2,282 JPY-0.92-25.46324.2KOff
5 Jun 20262,614 JPY-4.1%2,661 JPY2,279 JPY-0.73-26.8599.3KOn
29 May 20262,727 JPY2.4%2,653 JPY2,276 JPY-0.64-24.09828.6KOn
22 May 20262,663 JPY0.7%2,652 JPY2,271 JPY-0.65-22.95810.4KOn
15 May 20262,643 JPY-1.8%2,655 JPY2,267 JPY-0.59-21.691.2MOn
8 May 20262,693 JPY-0.5%2,655 JPY2,263 JPY-0.53-22.35334.4KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context